Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Feb 25 | HALO Halozyme Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 57.75 | 3,775 | 218.01 k | 28,489 |
23 Feb 25 | HALO Halozyme Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 7,012 | 0.00 | 32,264 |
23 Feb 25 | HALO Halozyme Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 7,012 | 0.00 | 21,033 |
20 Feb 25 | HALO Halozyme Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 21,327 | 0.00 | 21,327 |
20 Feb 25 | HALO Halozyme Therapeutics | Option to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 57.44 | 22,603 | 1.30 mm | 22,603 |
16 Feb 25 | HALO Halozyme Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 58.29 | 2,582 | 150.50 k | 25,252 |
16 Feb 25 | HALO Halozyme Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 4,796 | 0.00 | 27,834 |
16 Feb 25 | HALO Halozyme Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 58.29 | 9,373 | 546.35 k | 23,038 |
16 Feb 25 | HALO Halozyme Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 17,409 | 0.00 | 32,411 |
16 Feb 25 | HALO Halozyme Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 4,796 | 0.00 | 9,592 |